MCF Advisors LLC boosted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 43.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,388 shares of the healthcare conglomerate’s stock after buying an additional 423 shares during the period. MCF Advisors LLC’s holdings in UnitedHealth Group were worth $339,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Beaumont Financial Partners LLC grew its stake in shares of UnitedHealth Group by 11.8% in the 2nd quarter. Beaumont Financial Partners LLC now owns 4,858 shares of the healthcare conglomerate’s stock valued at $1,185,000 after purchasing an additional 512 shares during the last quarter. Pinnacle Wealth Planning Services Inc. grew its stake in shares of UnitedHealth Group by 18.5% in the 2nd quarter. Pinnacle Wealth Planning Services Inc. now owns 2,167 shares of the healthcare conglomerate’s stock valued at $529,000 after purchasing an additional 338 shares during the last quarter. Bank Hapoalim BM boosted its stake in shares of UnitedHealth Group by 73.9% in the second quarter. Bank Hapoalim BM now owns 9,413 shares of the healthcare conglomerate’s stock valued at $2,297,000 after buying an additional 4,000 shares in the last quarter. H D Vest Advisory Services boosted its stake in shares of UnitedHealth Group by 1.1% in the second quarter. H D Vest Advisory Services now owns 7,718 shares of the healthcare conglomerate’s stock valued at $1,883,000 after buying an additional 82 shares in the last quarter. Finally, Noesis Capital Mangement Corp purchased a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $409,000. 85.37% of the stock is currently owned by institutional investors.
A number of research firms recently weighed in on UNH. Morgan Stanley lifted their price target on UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a research note on Friday, July 12th. Citigroup raised UnitedHealth Group from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $247.00 to $280.00 in a report on Friday, May 10th. Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Monday, July 15th. Royal Bank of Canada set a $311.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a report on Friday, July 19th. Finally, Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price objective for the company in a report on Monday, July 22nd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $295.06.
Shares of NYSE UNH traded down $5.73 during trading on Thursday, reaching $234.62. The company had a trading volume of 2,260,452 shares, compared to its average volume of 3,151,811. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94. The stock has a market capitalization of $231.91 billion, a PE ratio of 18.22, a price-to-earnings-growth ratio of 1.30 and a beta of 0.61. The stock has a 50-day moving average price of $251.29 and a two-hundred day moving average price of $247.40. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.62.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The company had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. During the same period in the previous year, the firm posted $3.14 earnings per share. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. On average, sell-side analysts predict that UnitedHealth Group Inc will post 14.84 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a $1.08 dividend. The ex-dividend date is Friday, September 13th. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.84%. UnitedHealth Group’s dividend payout ratio (DPR) is 33.54%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: What is a Stop Order?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.